Abstract:Aims/hypothesisChemokine (C-X-C motif) ligand 12 (CXCL12) (also known as stromal cell-derived factor-1 [SDF-1]-alpha) is a homeostatic chemokine with multiple roles in cell homing, tumour metastasis, angiogenesis and tissue regeneration after acute injuries. However, its role in chronic diseases remains poorly defined, e.g. in chronic glomerular diseases like diabetic glomerulosclerosis. We hypothesised that CXCL12 may have a functional role during the evolution of diabetic glomerulosclerosis, either by assisting glomerular repair or by supporting the maladaptive tissue remodelling in response to hyperglycaemia and glomerular hyperfiltration.MethodsTo define the functional role of CXCL12 in the progression of glomerular disease, we used the CXCL12-specific inhibitor NOX-A12, an l-enantiomeric RNA oligonucleotide (Spiegelmer). A mouse model of type 2 diabetes (db/db mice) was used. Male db/db mice, uni-nephrectomised at 6 weeks of age, received subcutaneous injections with a PEGylated form of NOX-A12, non-functional control Spiegelmer or vehicle on alternate days from 4 to 6 months of age.ResultsImmunostaining localised renal CXCL12 production to glomerular podocytes in db/db mice with early or advanced diabetic nephropathy. CXCL12 inhibition significantly reduced the degree of glomerulosclerosis, increased the number of podocytes, prevented the onset of albuminuria and maintained the peritubular vasculature without affecting blood glucose levels, body weight or glomerular macrophage infiltration.Conclusions/interpretationWe conclude that podocytes produce CXCL12, which contributes to proteinuria and glomerulosclerosis in our mouse model of type 2 diabetes. This novel pathomechanism provides the first evidence that CXCL12 could be a therapeutic target in (diabetic) glomerulosclerosis.

The Role of CXCL12 in Kidney Diseases: A Friend or Foe?

Pathological roles of the homeostatic chemokine CXCL12

Regulation and function of CX3CR1 and its ligand CX3CL1 in kidney disease

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer

The role of CXCL12 in tumor microenvironment

Fractalkine (CX3CL1) and Its Receptor CX3CR1: A Promising Therapeutic Target in Chronic Kidney Disease?

Relevance of the chemokine CXCL12/CXCR7 axis in cardiovascular disease

CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis

Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes

Krüppel-like Factor 15: A Potential Therapeutic Target for Kidney Disease

The multiple faces of CXCL12 (SDF-1α) in the regulation of immunity during health and disease

Role of CX3CL1 in Diseases

CCL24/CCR3 Axis Plays a Central Role in Angiotensin II–induced Heart Failure by Stimulating M2 Macrophage Polarization and Fibroblast Activation

[Research Progress in Kidney Dendritic Cells].

The CXCL12 (SDF-1)/CXCR4 Chemokine Axis: Oncogenic Properties, Molecular Targeting, and Synthetic and Natural Product CXCR4 Inhibitors for Cancer Therapy.

The role of the CXCR6/CXCL16 axis in the pathogenesis of fibrotic disease

Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications

The Complement C3a and C3a Receptor Pathway in Kidney Diseases

The Role of Chemokine Receptor CXCR3 and Its Ligands in Renal Cell Carcinoma